For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Synthetic peptide against a region within the Human SOX2 protein
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Stable for 6 months from date of receipt.
Our Abpromise guarantee covers the use of ab139849 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||1/50 - 1/100.|
ab139849 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"